Physiologic Monitoring of Antidepressant Response

Completed · Phase 4 · Has a placebo group

Conditions studied: Major Depression

In brief

Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improvement in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not clinically indicated for a particular patient) are predictive of later clinical response.

Key facts

Study ID
NCT00792168
Run by
University of California, Los Angeles
People needed
38
Starts
1996-11-01
Expected to finish
1998-12-01
Last updated by the study team
2025-12-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.